BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11705599)

  • 21. Human papillomavirus infection and other risk factors for cervical intraepithelial neoplasia in Japan.
    Yoshikawa H; Nagata C; Noda K; Nozawa S; Yajima A; Sekiya S; Sugimori H; Hirai Y; Kanazawa K; Sugase M; Shimizu H; Kawana T
    Br J Cancer; 1999 May; 80(3-4):621-4. PubMed ID: 10408876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical cytology screening and management of abnormal cytology in adolescent girls.
    Kahn JA; Hillard PJ; ; ;
    J Pediatr Adolesc Gynecol; 2003 Jun; 16(3):167-71. PubMed ID: 12804942
    [No Abstract]   [Full Text] [Related]  

  • 23. Follow-up findings for women with human papillomavirus-positive and atypical squamous cells of undetermined significance screening test results in a large women's hospital practice.
    Armah H; Austin RM; Dabbs D; Zhao C
    Arch Pathol Lab Med; 2009 Sep; 133(9):1426-30. PubMed ID: 19722749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Summaries for patients. Results of Pap smears and human papillomavirus tests during cervical cancer screening.
    Ann Intern Med; 2008 Apr; 148(7):I32. PubMed ID: 18378942
    [No Abstract]   [Full Text] [Related]  

  • 25. HPV self-testing and cervical cancer screening coverage.
    Gravitt PE; Rositch AF
    Lancet Oncol; 2014 Feb; 15(2):128-9. PubMed ID: 24433681
    [No Abstract]   [Full Text] [Related]  

  • 26. The importance of HPV testing for cervical cancer screening in Israel.
    Levy T
    Isr Med Assoc J; 2017 Oct; 19(10):644-465. PubMed ID: 29103244
    [No Abstract]   [Full Text] [Related]  

  • 27. A decade has passed...the Pap smear and cervical cancer.
    Linder J
    Am J Clin Pathol; 1997 Nov; 108(5):492-8. PubMed ID: 9353086
    [No Abstract]   [Full Text] [Related]  

  • 28. [Human papillomavirus -- the major infectious factor in the process of cervical intraepithelial neoplasia].
    Zbroch T; Kanpp PG; Kanpp PA; Błońska E
    Med Wieku Rozwoj; 2004; 8(3 Pt 2):733-43. PubMed ID: 15858245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus as a form of risk assessment.
    Chew GK; Cruickshank ME
    Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):759-68. PubMed ID: 11563871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there a role for human papillomavirus testing in clinical practice?
    Kaufman RH
    Obstet Gynecol; 2001 Nov; 98(5 Pt 1):724-5. PubMed ID: 11704159
    [No Abstract]   [Full Text] [Related]  

  • 31. HPV testing is not useful for LSIL Triage--but stay tuned.
    Stoler MH
    Adv Anat Pathol; 2001 May; 8(3):160-4. PubMed ID: 11345239
    [No Abstract]   [Full Text] [Related]  

  • 32. Human papillomavirus type distribution among women with cervical pathology - a study over 4 years at Jimma Hospital, southwest Ethiopia.
    Bekele A; Baay M; Mekonnen Z; Suleman S; Chatterjee S
    Trop Med Int Health; 2010 Aug; 15(8):890-3. PubMed ID: 20545913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer.
    Ferreccio C; Bratti MC; Sherman ME; Herrero R; Wacholder S; Hildesheim A; Burk RD; Hutchinson M; Alfaro M; Greenberg MD; Morales J; Rodriguez AC; Schussler J; Eklund C; Marshall G; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):815-23. PubMed ID: 14504189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical neoplasia in the patient with HIV infection.
    Stratton P; Ciacco KH
    Curr Opin Obstet Gynecol; 1994 Feb; 6(1):86-91. PubMed ID: 8180357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adding human papillomavirus testing to cytology for primary cervical cancer screening: shooting first and asking questions later.
    Sawaya GF
    Ann Intern Med; 2008 Apr; 148(7):557-9. PubMed ID: 18378951
    [No Abstract]   [Full Text] [Related]  

  • 36. [Human papillomavirus and screening for cervical cancer: state of art and prospects].
    Meijer CJ; Rozendaal L; Voorhorst FJ; Verheijen R; Helmerhorst TJ; Walboomers JM
    Ned Tijdschr Geneeskd; 2000 Aug; 144(35):1675-9. PubMed ID: 10981235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of body mass index in incidence and persistence of cervical human papillomavirus infection.
    Urbute A; Thomsen LT; Belmonte F; Kesmodel US; Frederiksen K; Kjaer SK
    Ann Epidemiol; 2020 Sep; 49():36-41. PubMed ID: 32711054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between the progression of cervical dysplasia and the prevalence of human papillomavirus.
    Asato T; Nakajima Y; Nagamine M; Nakashima Y; Takei H; Maehama T; Yamashiro T; Higashi M; Nakayama M; Kanazawa K
    J Infect Dis; 1994 Apr; 169(4):940-1. PubMed ID: 8133117
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection of cervical intraepithelial neoplasia in women with atypical squamous or glandular cells of undetermined significance cytology: a prospective study.
    Wensveen C; Kagie M; Veldhuizen R; De Groot C; Denny L; Zwinderman K; Trimbos B
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):883-9. PubMed ID: 12911453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Less frequent Pap smears for low-risk women?
    Sanders FN
    S Afr Med J; 2004 Jun; 94(6):435-6. PubMed ID: 15250453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.